Explore evidence

81.5 %Fifty-three out of 65 patients who experienced virological failure carried a resistant virus, representing 81.5% of those who failed.

CamerounVIH/sidapublished 2013Journal of the International AIDS SocietyOpenAlexdocument of 3 observationsDOI 10.7448/ias.16.1.18004

7 %The prevalence of the 43E substitution in reverse transcriptase sequences was 7% among 57 HIV-1-infected treatment-naive individuals from Cameroon.

CamerounVIH/sidapublished 2011AIDS Research and Human RetrovirusesOpenAlexdocument of 24 observations

-0.34 SMDHIV infection was associated with lower diastolic blood pressure with a standardized mean difference of -0.34.

Cameroundiastolic blood pressure · VIH/sidapublished 2013International journal of epidemiologyeurope_pmcdocument of 10 observationsDOI 10.1093/ije/dyt198

0.92 hazard ratioThere was no significant difference between adult and adolescent hazard of death (HR=0.92, p=0.3793).

CamerounVIH/sidapublished 2012Journal of the International AIDS Societyeurope_pmcdocument of 39 observations

29.5 %Among patients with NRTI resistance, 13/44 (29.5%) accumulated at least three NRTI resistance mutations.

CamerounVIH/sidapublished 2013Journal of the International AIDS Societyeurope_pmcdocument of 4 observations

5.4 log10_copies_per_mlAt baseline, the median viral load was 5.4 log10 copies/ml.

CamerounVIH/sidaobserved baselinepublished 2005Antiviral TherapyOpenAlexdocument of 8 observationsDOI 10.1177/135965350501000208

98.7 %371 out of 376 patients (98.7%) started on a first-line antiretroviral regimen that included 3TC + d4T/AZT + NVP/EFV.

CamerounVIH/sidapublished 2013Journal of the International AIDS SocietyOpenAlexdocument of 3 observationsDOI 10.7448/ias.16.1.18004

0 %In 2010, 0% of 37 ART sites in Cameroon attained the target for on-time drug pick-up (target ≥ 90%).

CamerounVIH/sidaobserved 2010published 2012PLoS ONEOpenAlexdocument of 5 observationsDOI 10.1371/journal.pone.0036777

5.3 daysHIV-positive adult participants with CD4 350–550 worked 5.3 more days during the past month than those with CD4 <350.

CamerounVIH/sidapublished 2012Journal of the International AIDS Societyeurope_pmcdocument of 39 observations

53.7 %CRF02_AG accounted for 53.7% of the HIV-1 strains circulating among military personnel in Malabo, Equatorial Guinea.

CamerounVIH/sidapublished 2010AIDS research and human retroviruseseurope_pmcdocument of 4 observationsDOI 10.1089/aid.2010.0046

1,995 SFU/10^6 PBMCThe median magnitude of T cell response among responders was 1995 spot forming units per 10^6 PBMC.

CamerounVIH/sidapublished 2009RetrovirologyOpenAlexdocument of 6 observationsDOI 10.1186/1742-4690-6-s3-p273

8 %Between 2008 and June 2011, pregnant women constituted 683 (8%) of 8073 patient samples submitted for viral load testing.

CamerounVIH/sidaobserved 2008 to June 2011published 2012Journal of the International AIDS Societyeurope_pmcdocument of 39 observations

3.8 %HIV prevalence in the military of the Democratic Republic of Congo was 3.8%, higher than the general population prevalence of 1.3%.

CamerounVIH/sidapublished 2015International journal of STD & AIDSeurope_pmcdocument of 6 observations

2.8 %The A71V mutation was identified in 2.8% of the 142 HIV-1 isolates in the protease gene.

CamerounVIH/sidapublished 2000Journal of Clinical MicrobiologyOpenAlexdocument of 19 observations

10.2 %Among 128 patients routinely receiving highly active antiretroviral therapy in an HIV/AIDS outpatient clinic in Cameroon, 10.2% had resistance to non-NRTIs.

CamerounVIH/sidapublished 2006Emerging infectious diseasesOpenAlexdocument of 4 observationsDOI 10.3201/eid1206.050860

15 %Among HIV-1 protease (PR) sequences from drug-naïve Cameroonians, the secondary PI resistance-associated mutation 20R was present in 15% of strains.

CamerounVIH/sidapublished 2002Journal of Clinical MicrobiologyOpenAlexdocument of 12 observations

3.6 %At baseline, a prevalence of 3.6% HIV drug resistance was observed among 139 HIV-infected adult patients in Yaounde, Cameroon.

CamerounVIH/sidaobserved 2009-2011published 2013PLoS ONEOpenAlexdocument of 8 observationsDOI 10.1371/journal.pone.0072680

2.3 mmol/LRaised triglycerides were defined as >2.3 mmol/L in the study.

CamerounVIH/sidaobserved 2003–2014published 2018Global health, epidemiology and genomicseurope_pmcdocument of 2 observations

3,733 patientsA total of 3,733 patients were analyzed, including 2,036 (54.5%) who started ART at health centers and 1,697 (45.5%) at hospital level.

CamerounVIH/sidapublished 2012Journal of the International AIDS Societyeurope_pmcdocument of 39 observations

81 %The prevalence of the 371V substitution in reverse transcriptase sequences was 81% among 57 HIV-1-infected treatment-naive individuals from Cameroon.

CamerounVIH/sidapublished 2011AIDS Research and Human RetrovirusesOpenAlexdocument of 24 observations

12 %The use of tests with low specificities could imply inclusion of up to 12% HIV negative people in ART programs.

CamerounVIH/sidapublished 2009PLoS ONEOpenAlexdocument of 3 observationsDOI 10.1371/journal.pone.0007702

5 %The prevalence of the 11V substitution in protease sequences was 5% (3/57) among 57 HIV-1-infected treatment-naive individuals from Cameroon.

CamerounVIH/sidapublished 2011AIDS Research and Human RetrovirusesOpenAlexdocument of 24 observations

64 %Among unclassifiable protease (PR) sequences from HIV-1-infected, drug-naïve Cameroonians, 64% had dual and triple PI resistance-associated substitutions.

CamerounVIH/sidapublished 2002Journal of Clinical MicrobiologyOpenAlexdocument of 12 observations

61.9 %Crude, three-year retention was 61.9% (95% CI: 58.8–64.9) at hospitals.

CamerounVIH/sidapublished 2012Journal of the International AIDS Societyeurope_pmcdocument of 39 observations

89 specimensPhylogenetic analysis of the gp41 region of 123 HIV-1-seropositive specimens from Cameroon showed that 89 were subtype A.

CamerounVIH/sidapublished 2000AIDS Research and Human RetrovirusesOpenAlexdocument of 7 observations